Bombay Alkalodis Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.35 M
- Company Age 59 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 34.17%
- Profit Growth 136.52%
- Ebitda 127.64%
- Net Worth 34.00%
- Total Assets 18.09%
About Bombay Alkalodis
Bombay Alkalodis Private Limited (BAPL) was founded in India on 23 August 1965 and has a glorious history of 59 years and six months.Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Bombay Alkaloids Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.35 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmesh Shah, Ashwin Shah, and Silpa Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MH1965PTC013300
- Company No.
013300
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 1965
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bombay Alkalodis?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmesh Shah  | Director | 30-Nov-2015 | Current |
| Ashwin Shah | Director | 01-Apr-1991 | Current |
| Silpa Shah | Director | 22-Mar-2024 | Current |
Financial Performance of Bombay Alkalodis.
Bombay Alkalodis Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.17% increase. The company also saw a substantial improvement in profitability, with a 136.52% increase in profit. The company's net worth Soared by an impressive increase of 34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bombay Alkalodis?
In 2019, Bombay Alkalodis had a promoter holding of 27.29% and a public holding of 72.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Multilink Systems Private LimitedDharmesh Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bombay Alkalodis?
Unlock and access historical data on people associated with Bombay Alkalodis, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bombay Alkalodis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bombay Alkalodis's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
